risks of glp 1 medications Why do patients stop GLP-1 drugs? GLP-1 drugs are effective for

Weight management: Individuals with a BMI of 30 or higher or 27 or higher and associated conditions such as sleep apnea, high blood pressure or high cholesterol may qualify for GLP-1 medications as part of their treatment plan

Four novel NIPBL mutations in Japanese patients with Cornelia de Lange syndrome

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study

For a deeper look at vascular and cardiometabolic risk, see our pages on Preventive Cardiology and Silent Heart Disease Detection, Metabolic Health and Longevity Medicine, and ApoB and Longevity

Empagliflozin alleviates atherosclerosis progression by inhibiting inflammation and sympathetic activity in a normoglycemic mouse model

Free from artificial sweeteners, flavors, and colors, fillers, GMOs, gluten, common allergens and GMOs